Our research goal is to create innovative chemical tools, agents, and approaches for improving current targeted therapies for cancers and infectious diseases, including antibody-drug conjugates (ADCs). You can read on to find out more about these projects here.
January 4, 2021
Our paper on chemically constructed bispecific ADCs was accepted for publication in Bioorganic & Medicinal Chemistry!
December 21, 2020
Our preprint on dual-drug ADCs was posted on bioRxiv!
September 4, 2020
The lab was awarded NIH/NIGMS R35 MIRA award!
August 25, 2020
Our paper on ADCs for acute myeloid leukemia (AML) was accepted for publication in Molecular Cancer Therapeutics!
July 31, 2020
Dr. Yin Yuen Ha (Summer) joined our Lab!
May 15, 2020
Travis left the lab to start his graduate study at University of Connecticut. Good Luck!
October 24, 2019
Our book chapter on transglutaminase-mediated ADC construction was published in Methods in Molecular Biology!
September 30, 2019
The lab was awarded another DOD BCRP grant (Funding Level 1)!
July 15, 2019
Travis joined our lab!
April 1, 2019
Yasuaki and Aiko were awarded the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship! Congratulations!!